Fresenius Still Awaits FTC Approval to Buy NxStage Medical
The company expects the delayed transaction to close early this year.
Read the full article » | Posted 01-11-2019
Related Articles
- Outset Medical Beat Q2 Wall Street Projections Posted 09-14-2021
- Fresenius Invests to Help Humacyte Develop Implantable Blood Vessels Posted 09-14-2021
- Diality Appoints Chief Business Officer Posted 08-12-2021
- FMC-NA Names Joe Turk New President for Renal Therapies Group Posted 08-12-2021